
Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung cancer in the phase 1b FURTHER trial.
We asked our readers, what is the most important lesson cancer has taught you?
We recently asked our Heal readers to share the most important lesson that cancer has taught them, and their answers ran the gamut. Here, we share some of the most poignant responses:
almost 7 years ago
The Secret Side Effect of Survivorship: Survivor's Guiltalmost 7 years ago
Breaking the Icealmost 7 years ago
The Pink Hulk: Drawing on the Power Withinalmost 7 years ago
New Guidelines Call for Gene Screening for Cancer Survivorsalmost 7 years ago
A Little Sleep Education May Improve Insomniaalmost 7 years ago
With Help, You Can Overcome Survivor's Guilt





